University of Florida College of Pharmacy Dean and Distinguished Professor Julie Johnson, Pharm.D., has been named a Thomson Reuters Highly Cited Researcher for the second consecutive year. The honor is given to the world’s leading scholars in the sciences and social sciences and is earned by being among the top one percent most cited researchers in a subject field.
Johnson was featured in the Pharmacology and Toxicology category – one of 21 broad fields of science recognized by Thomson Reuters. She is recognized internationally as one of the leading researchers in the field of pharmacogenomics. During her academic career, she has secured nearly $40 million in funding as a principal investigator and written more than 250 original articles.
Thomson Reuters analyzes citation data over an 11-year period to identify scholars worthy of the Highly Cited Researcher distinction. About 3,000 researchers globally earn the honor every year.